Jane Street’s Kronos Bio KRON Stock Holding History

Jane Street’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-32,071	Closed	-$26.5K	–	10308
2025 Q1	$26.5K	Buy	32,071 +9,291	+41%	+$8.95K	﹤0.01%	9112
2024 Q4	$21.6K	Buy	+22,780	New	+$21.5K	﹤0.01%	9125
2024 Q3	–	Sell	-77,688	Closed	-$96.3K	–	10040
2024 Q2	$96.3K	Buy	77,688 +59,279	+322%	+$60.4K	﹤0.01%	8739
2024 Q1	$23.9K	Sell	18,409 -670	-4%	-$764	﹤0.01%	8877
2023 Q4	$23.8K	Sell	19,079 -12,727	-40%	-$14.1K	﹤0.01%	8889
2023 Q3	$41.3K	Buy	31,806 +18,553	+140%	+$30K	﹤0.01%	8191
2023 Q2	$22.8K	Buy	+13,253	New	+$21K	﹤0.01%	8345
2023 Q1	–	Sell	-23,561	Closed	-$38.2K	–	9502
2022 Q4	$38.2K	Buy	+23,561	New	+$54.2K	﹤0.01%	8446

Jane Street's KRON Position: Q2 2025 in Review

Jane Street sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 32,071 shares — an estimated $26.5K sold.

Jane Street first reported a position in KRON in Q4 2022 and held it in 8 quarters. The position peaked at $96.3K in Q2 2024. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.

Jane Street reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
Jane Street sold 32,071 Kronos Bio shares in Q2 2025, an estimated $26.5K.
Jane Street first reported a position in Kronos Bio in Q4 2022 and held it in 8 quarters.
Jane Street's Kronos Bio position peaked at $96.3K in Q2 2024.
0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.